For laboratory research use only. Not for human consumption.
Free U.S. shipping on $200+GLPZone / The research collection
Illustrative certificateNS-2026-06036Nordicstar Analytical Sciences
BPC-157 5 MG
Illustrative certificateNS-2026-06037Nordicstar Analytical Sciences
BPC-157 10 MG
Repair & Recovery
Fibroblast signaling & experimental tissue models
A pair saves 10%. A set of three saves 15%.
For laboratory research use only.
Not for human consumption or clinical use.
The records shown here are illustrative. Request laboratory-issued documentation for your lot before ordering.
Priority, tracked shipping within the United States, free on orders of $200 or more after savings. Add Priority dispatch at checkout to have your order packed first; Private Clients receive it on every order. Follow the product documentation for laboratory handling requirements.
Shipping information01 / The compound
Fibroblast signaling & experimental tissue models
BPC-157 is a synthetic 15-amino-acid peptide corresponding to a characterized fragment of a larger body protection compound described in human gastric juice. Its amino-acid sequence is GEPPPGKPADDAGLV.
Published BPC-157 research is predominantly preclinical and includes animal models, cultured cells and isolated tissue systems used to investigate tendon biology, ligament repair, angiogenic signaling, gastric models and growth-hormone receptor expression.
02 / Research profile
A definitive molecular mechanism has not been established. Current research has investigated several pathways that may contribute to observed effects in experimental models.
FAK / Paxillin Signaling: Tendon-fibroblast research has examined activation of the FAK/paxillin pathway in association with cell migration and spreading.
Growth-Hormone Receptor / JAK2: Laboratory studies have reported increased growth-hormone receptor expression in tendon fibroblasts and investigated downstream JAK2 signaling.
VEGF / VEGFR2: Preclinical research has examined VEGF expression, VEGFR2 activation and vascular responses in tissue-healing and angiogenesis models.
Nitric-Oxide Signaling: Animal and tissue studies have also investigated interactions between BPC-157 and nitric-oxide-related pathways in gastrointestinal and vascular models.
BPC-157 has been studied in preclinical tendon and ligament models. Research has examined tendon-fibroblast migration, cell survival, FAK/paxillin signaling and structural recovery following experimental ligament injury. These findings come primarily from laboratory and animal research.
Studies using tendon fibroblasts have investigated changes in cellular migration and signaling pathways associated with tissue response. Separate laboratory work has reported increased growth-hormone receptor expression in BPC-157-treated tendon fibroblasts and examined downstream JAK2 signaling.
BPC-157 has a long history of investigation in experimental gastrointestinal models. Animal studies have examined gastric and duodenal lesions, mucosal injury, inflammatory responses and signaling pathways associated with gastrointestinal tissue integrity.
Preclinical studies have investigated BPC-157 in relation to angiogenesis, VEGF and VEGFR2 signaling. Results differ by model: earlier cell-culture research did not find a direct angiogenic effect, while animal and later experimental models reported changes in vascular signaling during tissue repair.
Reading the evidence
The BPC-157 literature is dominated by preclinical research. Published studies include rodent models of tendon and ligament injury, gastric models, cultured tendon fibroblasts and investigations of VEGFR2-associated signaling. Results should be interpreted within the experimental model used in each publication rather than generalized beyond those conditions.
03 / Reference data
Reference specifications describe a compound. The final lot documentation identifies the material supplied.
| Compound | BPC-157 |
|---|---|
| Research area | Repair & Recovery |
| CAS number | 137525-51-0 |
| Molecular formula | C62H98N16O22 |
| Molecular weight | 1419.5 g/mol |
| Physical form | Lyophilized |
| Vial options | 5 MG · 10 MG |
| Intended use | Laboratory research only |
Variant amounts are nominal catalog quantities. They are not instructions for use.
HPLC separates components under a defined method. Read the reported percentage alongside the chromatogram, wavelength, integration method, and scope of the test.
Mass spectrometry provides molecular-mass evidence. Identity and chromatographic purity answer different questions; one cannot stand in for the other.
Connect the product name, variant, lot identifier, report date, and issuing laboratory. A report is useful only when its sample can be linked to the material being reviewed.
Every BPC-157 lot is analyzed by Nordicstar Analytical Sciences for identity, content, and purity by HPLC with LC-MS confirmation. Each certificate carries a report number and verification key that can be checked at nordicstarlabs.com/verify. Research references below describe published science, not a certificate for a vial.
Read a COA with confidence| Presentation | Lot | HPLC purity | Tested | Certificate |
|---|---|---|---|---|
| 10 MG Current lot | GLZ-26-BPC157-1036 | 99.683% | 20 Sep 2026 | NS-2026-06037 |
| 5 MG Current lot | GLZ-26-BPC157-1035 | 99.645% | 19 Sep 2026 | NS-2026-06036 |
| 5 MG | GLZ-26-BPC157-765 | 99.560% | 16 Aug 2026 | NS-2026-06143 |
| 10 MG | GLZ-26-BPC157-764 | 99.705% | 14 Aug 2026 | NS-2026-06145 |
| 5 MG | GLZ-26-BPC157-665 | 99.667% | 09 Jul 2026 | NS-2026-06144 |
| 10 MG | GLZ-26-BPC157-664 | 99.591% | 07 Jul 2026 | NS-2026-06146 |
05 / Storage & handling
Keep sealed research material protected from moisture, unnecessary light and temperature fluctuations. Use the storage conditions documented for the specific compound, formulation and lot.
Solution stability depends on solvent, concentration, container and experimental conditions. Use a validated laboratory protocol; a universal post-reconstitution shelf life is not established by the literature summaries.
Explore the handling guide06 / Common questions
No. The cited work investigates several pathways, including FAK/paxillin, growth-hormone receptor/JAK2, VEGF/VEGFR2 and nitric-oxide signaling. Observations differ between cell, tissue and animal models.
BPC-157 is the 15-residue sequence GEPPPGKPADDAGLV. TB-500 is associated with the acetylated seven-residue thymosin beta-4 fragment Ac-LKKTETQ. Their chemical identities and research histories are different.
07 / Further reading
Selected literature for context. Read each study’s methods, experimental model, and limitations alongside its findings.
Curated pairings
